S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Zacks: Brokerages Expect Umpqua Holdings Co. (NASDAQ:UMPQ) Will Announce Quarterly Sales of $297.37 Million

Last updated on Saturday, May 14, 2022 | 2022 MarketBeat

Equities research analysts predict that Umpqua Holdings Co. (NASDAQ:UMPQ - Get Rating) will report sales of $297.37 million for the current quarter, Zacks reports. Three analysts have made estimates for Umpqua's earnings, with the lowest sales estimate coming in at $292.40 million and the highest estimate coming in at $300.00 million. Umpqua posted sales of $320.84 million during the same quarter last year, which suggests a negative year-over-year growth rate of 7.3%. The company is expected to announce its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that Umpqua will report full year sales of $1.58 billion for the current year, with estimates ranging from $1.57 billion to $1.59 billion. For the next fiscal year, analysts anticipate that the company will post sales of $2.04 billion, with estimates ranging from $1.98 billion to $2.11 billion. Zacks Investment Research's sales averages are an average based on a survey of sell-side analysts that follow Umpqua.

Umpqua (NASDAQ:UMPQ - Get Rating) last issued its quarterly earnings data on Wednesday, April 20th. The bank reported $0.42 EPS for the quarter, topping the consensus estimate of $0.39 by $0.03. Umpqua had a return on equity of 14.89% and a net margin of 31.34%. The company had revenue of $308.73 million during the quarter, compared to analyst estimates of $296.38 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. Umpqua's revenue was down 6.5% compared to the same quarter last year.


UMPQ has been the subject of several recent research reports. Zacks Investment Research lowered Umpqua from a "strong-buy" rating to a "hold" rating in a report on Thursday, March 31st. StockNews.com assumed coverage on Umpqua in a research note on Thursday, March 31st. They issued a "hold" rating for the company. Finally, Keefe, Bruyette & Woods assumed coverage on Umpqua in a research note on Friday, February 11th. They issued a "market perform" rating for the company. Seven analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $20.90.

Shares of UMPQ opened at $16.70 on Friday. The business has a fifty day moving average of $18.55 and a 200 day moving average of $19.72. Umpqua has a one year low of $16.40 and a one year high of $22.06. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.94 and a quick ratio of 0.93. The firm has a market capitalization of $3.62 billion, a P/E ratio of 9.03 and a beta of 1.02.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 27th. Stockholders of record on Monday, May 16th will be issued a $0.21 dividend. The ex-dividend date is Friday, May 13th. This represents a $0.84 annualized dividend and a dividend yield of 5.03%. Umpqua's payout ratio is 45.41%.

In other news, CFO Ron L. Farnsworth sold 7,000 shares of the stock in a transaction that occurred on Wednesday, March 2nd. The stock was sold at an average price of $20.49, for a total value of $143,430.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Cort L. O'haver sold 5,000 shares of the stock in a transaction that occurred on Wednesday, March 2nd. The stock was sold at an average price of $20.21, for a total value of $101,050.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,000 shares of company stock worth $332,830. Company insiders own 0.58% of the company's stock.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Clean Yield Group raised its stake in shares of Umpqua by 0.3% during the 4th quarter. Clean Yield Group now owns 157,139 shares of the bank's stock valued at $3,023,000 after buying an additional 495 shares during the last quarter. US Bancorp DE raised its stake in shares of Umpqua by 0.8% during the 3rd quarter. US Bancorp DE now owns 69,662 shares of the bank's stock valued at $1,411,000 after buying an additional 559 shares during the last quarter. Commerce Bank raised its stake in shares of Umpqua by 2.9% during the 4th quarter. Commerce Bank now owns 19,724 shares of the bank's stock valued at $380,000 after buying an additional 560 shares during the last quarter. Raymond James & Associates raised its stake in shares of Umpqua by 3.5% during the 3rd quarter. Raymond James & Associates now owns 16,931 shares of the bank's stock valued at $343,000 after buying an additional 572 shares during the last quarter. Finally, CI Investments Inc. raised its stake in shares of Umpqua by 8.1% during the 3rd quarter. CI Investments Inc. now owns 7,901 shares of the bank's stock valued at $160,000 after buying an additional 591 shares during the last quarter. 87.58% of the stock is currently owned by institutional investors and hedge funds.

Umpqua Company Profile (Get Rating)

Umpqua Holdings Corporation operates as the holding company of Umpqua Bank that provides commercial and retail banking services. It operates in two segments: Core Banking and Mortgage Banking. The company offers deposit products, including non-interest bearing checking, interest bearing checking and savings, and money market accounts, as well as certificates of deposit.

Read More

Get a free copy of the Zacks research report on Umpqua (UMPQ)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Umpqua (NASDAQ:UMPQ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Umpqua right now?

Before you consider Umpqua, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Umpqua wasn't on the list.

While Umpqua currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.